Article
Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii strains isolated from Aegean region of Turkey.
Parasitology research - 1 Oct 2018
Ozkoc Soykan, Erguden Ceren, Bayram Delibas Songul
Abstract excerpt
Sulfonamide group drugs and their antimetabolite combinations are the most preferred drugs in the treatment and prophylaxis of Pneumocystis jirovecii pneumonia (PCP). Especially with the long-term use of trimethoprim-sulfamethoxazole (TMP-SMX) and dapsone, certain point mutations in the Pneumocystis jirovecii (P. jirovecii) dihydropteroate synthase (DHPS) gene are known to play an important role in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
